HemoSphere
Device Hemodynamic Monitoring
PDI 00690103197006
General payments
$2,008,770
Research payments
$6,999,094
Through program year 2025, $2,008,770 in general payments and $6,999,094 in research payments were reported against HemoSphere (Hemodynamic Monitoring).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $399,347 | 6,873 |
| 2025 | Research | $479,205 | 7 |
| 2024 | General | $390,502 | 6,344 |
| 2024 | Research | $1,053,703 | 16 |
| 2023 | General | $359,892 | 4,997 |
| 2023 | Research | $227,513 | 8 |
| 2022 | General | $429,854 | 4,146 |
| 2022 | Research | $3,374,432 | 93 |
| 2021 | General | $429,174 | 3,168 |
| 2021 | Research | $1,864,242 | 46 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 92 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
25,528 general · 170 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.